Comprehensive Review of Rothmund-Thomson Syndrome: Clinical Manifestations, Molecular Pathogenesis, and Therapeutic Approaches
Main Article Content
Abstract
Rothmund-Thomson syndrome (RTS) is a rare autosomal recessive genodermatosis characterized by a spectrum of clinical manifestations, including poikiloderma, sparse hair, short stature, skeletal abnormalities, and an increased predisposition to malignancies, particularly osteosarcoma. This syndrome is primarily associated with mutations in the RECQL4 gene, a critical player in DNA repair and genomic stability. This review provides an in-depth analysis of the clinical presentation, underlying molecular mechanisms, and current therapeutic strategies for RTS. We aim to elucidate the genetic and cellular pathways implicated in RTS, highlight the challenges in clinical management, and explore potential future directions in research and therapy.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
I. Wang LL, Levy LL, Lewis RA, Chintagumpala MM, Lev D, Rogers M, et al. Clinical manifestations in a cohort of 41 Rothmund-Thomson syn- drome patients. Am J Med Genet. 2001;102:11-7.
II. Silverberg NB, Biro DE, Laude TA. What syndrome is this? Roth-mund-Thomson syndrome (poikiloderma congenitale). Pediatr Dermatol. 1999;16:59-61.
III. Larizza L, Roversi G, Volpi L. Rothmund-Thomson syndrome. Orphanet J Rare Dis. 2010;5:2.
IV. Ajeawung NF, Nguyen TTM, Lu L, Kucharski TJ, Rousseau J, Molidperee S, et al. Mutations in ANAPC1, encoding a scaffold subunit of the anaphase-promoting complex, cause Rothmund-Thomson syndrome type 1. Am J Hum Genet. 2019;105:625-30.
V. Lindor NM, Furuichi Y, Kitao S, Shimamoto A, Arndt C, Jalal S. Roth- mund-Thomson syndrome due to RECQ4 helicase mutations: report and clinical and molecular comparisons with Bloom syndrome and Werner syndrome. Am J Med Genet. 2000;90:223-8.
VI. Wu J, Capp C, Feng L, Hsieh TS. Drosophila homologue of the Rothmund–Thomson syndrome gene: essential function in DNA replication during development. Dev Biol. 2008;323:130-42.
VII. Lu L, Jin W, Liu H, Wang LL. Aging in Rothmund-Thomson syndrome and related RECQL4 genetic disorders. Ageing Res Rev. 2017;33:30-35.
VIII. Lu L, Jin W, Wang LL. RECQ DNA helicases and osteosarcoma. Adv Exp Med Biol. 2020;1258:37-54.
IX. Sangrithi MN, Bernal JA, Madine M, Philpott A, Lee J, Dunphy WG, et al. Initiation of DNA replication requires the RECQL4 protein mutated in Rothmund-Thomson syndrome. Cell. 2005;121:887-98.
X. Simon T, Kohlhase J, Wilhelm C, Kochanek M, De Carolis B, Berthold F. Multiple malignant diseases in a patient with Rothmund-Thomson syndrome with RECQL4 mutations: case report and literature review. Am J Med Genet A. 2010;152A:1575-9.
XI. Piquero-Casals J, Okubo AY, Nico MM. Rothmund-Thomson syndrome in three siblings and development of cutaneous squamous cell carcinoma. Pediatr Dermatol. 2002;19:312-6.
XII. Kumar P, Sharma PK, Gautam RK, Jain RK, Kar HK. Late-onset Rothmund-Thomson syndrome. Int J Dermatol. 2007;46:492-3.
XIII. Gupta S, De S, Srivastava V, Hussain M, Kumari J, Muniyappa K, et al. RECQL4 and p53 potentiate the activity of polymerase and maintain the integrity of the human mitochondrial genome. Carcinogenesis. 2014;35:34-45.
XIV. Green JS, Rickett AB. Rothmund-Thomson syndrome complicated by osteosarcoma. Pediatr Radiol. 1998;28:48-50.
XV. Colsante MV, Gómez ML, Valente EE, Cabrera HN, García SA. Síndrome de Rothmund-Thomson, poiquilodermia congénita. Arch Arg Dermatol. 2002;52:153-8.
XVI. Arnold AW, Itin PH, Pigors M, Kohlhase J, Bruckner-Tuderman L, Has C. Poikiloderma with neutropenia: a novel C16orf57 mutation and clinical diagnostic criteria. Br J Dermatol. 2010;163:866-9.